Canada Life’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $499K | Hold |
35,623
| – | – | ﹤0.01% | 1502 |
|
|
2025
Q4 | $400K | Sell |
35,623
-44,248
| -55% | -$506K | ﹤0.01% | 1545 |
|
|
2025
Q3 | $921K | Hold |
79,871
| – | – | ﹤0.01% | 1462 |
|
|
2025
Q2 | $977K | Buy |
79,871
+7,647
| +11% | +$96.2K | ﹤0.01% | 1440 |
|
|
2025
Q1 | $1.03M | Sell |
72,224
-3,117
| -4% | -$48.7K | ﹤0.01% | 1423 |
|
|
2024
Q4 | $1.2M | Buy |
75,341
+13,634
| +22% | +$270K | ﹤0.01% | 1426 |
|
|
2024
Q3 | $1.48M | Buy |
61,707
+4,934
| +9% | +$113K | ﹤0.01% | 1401 |
|
|
2024
Q2 | $1.13M | Buy |
56,773
+11,604
| +26% | +$226K | ﹤0.01% | 1478 |
|
|
2024
Q1 | $900K | Hold |
45,169
| – | – | ﹤0.01% | 1526 |
|
|
2023
Q4 | $1.01M | Hold |
45,169
| – | – | ﹤0.01% | 1503 |
|
|
2023
Q3 | $914K | Sell |
45,169
-1,362
| -3% | -$30.9K | ﹤0.01% | 1515 |
|
|
2023
Q2 | $1.19M | Sell |
46,531
-2,388
| -5% | -$62.9K | ﹤0.01% | 1442 |
|
|
2023
Q1 | $1.46M | Sell |
48,919
-2,399
| -5% | -$69.7K | ﹤0.01% | 1371 |
|
|
2022
Q4 | $1.39M | Sell |
51,318
-5,705
| -10% | -$140K | ﹤0.01% | 1407 |
|
|
2022
Q3 | $1.24M | Buy |
57,023
+9,718
| +21% | +$254K | ﹤0.01% | 1395 |
|
|
2022
Q2 | $1.29M | Buy |
47,305
+5,686
| +14% | +$163K | ﹤0.01% | 1374 |
|
|
2022
Q1 | $1.43M | Hold |
41,619
| – | – | ﹤0.01% | 1367 |
|
|
2021
Q4 | $1.44M | Buy |
41,619
+130
| +0.3% | +$4.2K | ﹤0.01% | 1369 |
|
|
2021
Q3 | $1.3M | Hold |
41,489
| – | – | ﹤0.01% | 1414 |
|
|
2021
Q2 | $1.51M | Buy |
41,489
+23,011
| +125% | +$952K | ﹤0.01% | 1311 |
|
|
2021
Q1 | $807K | Sell |
18,478
-2,299
| -11% | -$108K | ﹤0.01% | 1591 |
|
|
2020
Q4 | $953K | Sell |
20,777
-2,360
| -10% | -$98.2K | ﹤0.01% | 1527 |
|
|
2020
Q3 | $768K | Sell |
23,137
-1,704
| -7% | -$54.5K | ﹤0.01% | 1518 |
|
|
2020
Q2 | $729K | Sell |
24,841
-173
| -0.7% | -$5.01K | ﹤0.01% | 1569 |
|
|
2020
Q1 | $674K | Buy |
25,014
+1,711
| +7% | +$51.1K | ﹤0.01% | 1488 |
|
|
2019
Q4 | $779K | Buy |
+23,303
| New | +$844K | ﹤0.01% | 1590 |
|
|
2019
Q3 | – | Sell |
-28,296
| Closed | -$1.23M | – | 1219 |
|
|
2019
Q2 | $1.23M | Sell |
28,296
-1,385
| -5% | -$59.2K | ﹤0.01% | 1436 |
|
|
2019
Q1 | $1.27M | Buy |
29,681
+1,210
| +4% | +$54.2K | ﹤0.01% | 1295 |
|
|
2018
Q4 | $1.18M | Buy |
28,471
+2,542
| +10% | +$133K | ﹤0.01% | 1327 |
|
|
2018
Q3 | $1.78M | Sell |
25,929
-143,197
| -85% | -$9.22M | ﹤0.01% | 1247 |
|
|
2018
Q2 | $9.69M | Sell |
169,126
-33,648
| -17% | -$1.78M | 0.02% | 538 |
|
|
2018
Q1 | $9.34M | Buy |
202,774
+173,245
| +587% | +$8.23M | 0.02% | 552 |
|
|
2017
Q4 | $1.36M | Buy |
29,529
+2,330
| +9% | +$107K | ﹤0.01% | 1389 |
|
|
2017
Q3 | $1.24M | Sell |
27,199
-710
| -3% | -$30.3K | ﹤0.01% | 1442 |
|
|
2017
Q2 | $1.1M | Buy |
27,909
+1,311
| +5% | +$49.5K | ﹤0.01% | 1483 |
|
|
2017
Q1 | $1.01M | Hold |
26,598
| – | – | ﹤0.01% | 1502 |
|
|
2016
Q4 | $985K | Sell |
26,598
-2,300
| -8% | -$82.2K | ﹤0.01% | 1486 |
|
|
2016
Q3 | $1M | Buy |
28,898
+2,604
| +10% | +$91.2K | ﹤0.01% | 1443 |
|
|
2016
Q2 | $855K | Buy |
26,294
+22,169
| +537% | +$679K | ﹤0.01% | 1484 |
|
|
2016
Q1 | $118K | Hold |
4,125
| – | – | ﹤0.01% | 1677 |
|
|
2015
Q4 | $138K | Sell |
4,125
-53
| -1% | -$1.65K | ﹤0.01% | 1526 |
|
|
2015
Q3 | $120K | Sell |
4,178
-18
| -0.4% | -$628 | ﹤0.01% | 1577 |
|
|
2015
Q2 | $170K | Hold |
4,196
| – | – | ﹤0.01% | 1462 |
|
|
2015
Q1 | $206K | Sell |
4,196
-23,986
| -85% | -$1.11M | ﹤0.01% | 1334 |
|
|
2014
Q4 | $1.28M | Buy |
+28,182
| New | +$1.11M | ﹤0.01% | 861 |
|
Other funds holding AVNS
AC
VCM
VPM
Canada Life's AVNS Position: Q1 2026 in Review
Canada Life held its Avanos Medical (AVNS) position steady in Q1 2026 at 35,623 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1502.
Canada Life first reported a position in AVNS in Q4 2014 and has held it in 45 quarters since. The position peaked at $9.69M in Q2 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Canada Life held 35,623 shares of Avanos Medical worth $499K as of Q1 2026.
- Canada Life left its Avanos Medical share count unchanged in Q1 2026.
- Avanos Medical made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1502 holding.
- Canada Life first reported a position in Avanos Medical in Q4 2014 and has held it in 45 quarters since.
- Canada Life's Avanos Medical position peaked at $9.69M in Q2 2018.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.